{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T21:12:23Z","timestamp":1723151543356},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12094-012-0917-9","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T13:05:02Z","timestamp":1343048702000},"page":"300-306","source":"Crossref","is-referenced-by-count":8,"title":["Zoledronic acid and radiation: toxicity, synergy or radiosensitization?"],"prefix":"10.1007","volume":"15","author":[{"given":"M.","family":"Alcaraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Armero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alcaraz-Saura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Achel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"917_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lungcan.2009.08.020","volume":"67","author":"C Langer","year":"2010","unstructured":"Langer C, Hirsh V (2010) Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates. Lung Cancer 67:4\u201311","journal-title":"Lung Cancer"},{"issue":"3","key":"917_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157488709789957718","volume":"4","author":"S Ricciardi","year":"2009","unstructured":"Ricciardi S, Marinis F (2009) Treatment of bone metastases in lung cancer: the actual role of zoledronic acid. Rev Recent Clin Trials 4(3):205\u2013211","journal-title":"Rev Recent Clin Trials"},{"key":"917_CR3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ctrv.2008.03.006","volume":"34","author":"T Guise","year":"2008","unstructured":"Guise T (2008) Antitumor effects of bisphosphonates: promising preclinical evidence. Cancer Treat Rev 34:S19\u2013S24","journal-title":"Cancer Treat Rev"},{"key":"917_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ctrv.2008.02.004","volume":"34","author":"MC Winter","year":"2008","unstructured":"Winter MC, Holen I, Coleman RE (2008) Exploring the anti-tumor activity of bisphosphonates in early breast cancer. Cancer Treat Rev 34:453\u2013475","journal-title":"Cancer Treat Rev"},{"issue":"Suppl 2","key":"917_CR5","first-page":"E88","volume":"10","author":"Y Jimenez-Soriano","year":"2005","unstructured":"Jimenez-Soriano Y, Bagan JV (2005) Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update. Med Oral Patol Oral Cir Bucal 10(Suppl 2):E88\u2013E91","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"917_CR6","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.seminoncol.2010.10.005","volume":"37","author":"G Morgan","year":"2010","unstructured":"Morgan G, Lipton A (2010) Antitumor effects and anticancer applications of bisphosphonates. Semin Oncol 37:S30\u2013S40","journal-title":"Semin Oncol"},{"key":"917_CR7","first-page":"864","volume":"140","author":"A Soulafa","year":"2009","unstructured":"Soulafa A, Almazrooa BDS, Sook-Bin W (2009) Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. JADA 140:864\u2013875","journal-title":"JADA"},{"key":"917_CR8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ejca.2010.02.041","volume":"46","author":"HL Neville-Webbe","year":"2010","unstructured":"Neville-Webbe HL, Coleman RE (2010) Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease. Eur J Cancer 46:1211\u20131222","journal-title":"Eur J Cancer"},{"issue":"5","key":"917_CR9","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.ejca.2009.04.022","volume":"4","author":"RE Coleman","year":"2009","unstructured":"Coleman RE (2009) Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy? Eur J Cancer 4(5):1909\u20131915","journal-title":"Eur J Cancer"},{"key":"917_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijrobp.2004.09.065","volume":"61","author":"E Algur","year":"2005","unstructured":"Algur E, Macklis RM, Hafeli UO (2005) Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines. Int J Radiat Oncol Biol Phys 61:535\u2013542","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"917_CR11","first-page":"1","volume":"8","author":"AU Ural","year":"2006","unstructured":"Ural AU, Avcu F, Candir M et al (2006) In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. Breast Cancer Res 8:1\u20137","journal-title":"Breast Cancer Res"},{"key":"917_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lungcan.2004.06.003","volume":"47","author":"S Matsumoto","year":"2005","unstructured":"Matsumoto S, Kimura S, Segawa H, Kuroda J, Yuasa T, Sato K, Nogawa M, Tanaka F, Maekawa T, Wada H (2005) Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines. Lung Cancer 47:31\u201339","journal-title":"Lung Cancer"},{"key":"917_CR13","first-page":"936","volume":"47","author":"J Carmichael","year":"1987","unstructured":"Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936\u2013942","journal-title":"Cancer Res"},{"key":"917_CR14","first-page":"943","volume":"47","author":"J Carmichael","year":"1987","unstructured":"Carmichael J, DeGraff WG, Gazdar AF, Minna JO, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47:943\u2013946","journal-title":"Cancer Res"},{"key":"917_CR15","first-page":"589","volume":"48","author":"MC Alley","year":"1988","unstructured":"Alley MC, Scudiero OA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589\u2013601","journal-title":"Cancer Res"},{"key":"917_CR16","first-page":"18","volume":"30","author":"JR Vicente","year":"1997","unstructured":"Vicente JR, Ortega VV, Jordana MC (1997) Valor del ensayo colorim\u00e9trico con MTT en el estudio de crecimiento y citotoxicidad in vitro de l\u00edneas de melanoma. Patologia 30:18\u201327","journal-title":"Patologia"},{"key":"917_CR17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","volume":"5","author":"M Fenech","year":"2007","unstructured":"Fenech M (2007) Cytokinesis block micronucleus cytome assay. Nat Protoc 5:1084\u20131104","journal-title":"Nat Protoc"},{"key":"917_CR18","volume-title":"Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies","author":"International Atomic Energy Agency","year":"2011","unstructured":"International Atomic Energy Agency (2011) Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies. IAEA, Vienna"},{"key":"917_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1259\/dmfr\/95408354","volume":"40","author":"M Alcaraz","year":"2011","unstructured":"Alcaraz M, Armero D, Mart\u00ednez-Beneyto Y, Castillo J, Benavente-Garcia O, Fernandez H, Alcaraz-Saura M, Canteras M (2011) Chemical genoprotection: reducing biological damage to as low as reasonably achievable levels. Dentomaxillofac Radiol 40:310\u2013314","journal-title":"Dentomaxillofac Radiol"},{"key":"917_CR20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/09553009314552161","volume":"63","author":"L Sarma","year":"1993","unstructured":"Sarma L, Kesavan PC (1993) Protective effects of vitamina C and E against \u03b3-ray-induced chromosomal damage in mouse. Int J Radiat Biol 63:759\u2013764","journal-title":"Int J Radiat Biol"},{"key":"917_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2005.06.003","volume":"50","author":"AU Ural","year":"2005","unstructured":"Ural AU, Avcu F (2005) Radiosensitizing effect of zoledronic acid in small cell lung cancer. Lung Cancer 50:271\u2013272 (letter)","journal-title":"Lung Cancer"},{"key":"917_CR22","volume-title":"Radiobiology for the radiobiologist","author":"EJ Hall","year":"1978","unstructured":"Hall EJ (1978) Radiobiology for the radiobiologist, 2nd edn. Harper do Row publishers, Philadelphia","edition":"2"},{"key":"917_CR23","first-page":"3506","volume":"54","author":"L Milas","year":"1994","unstructured":"Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ (1994) Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54:3506\u20133510","journal-title":"Cancer Res"},{"key":"917_CR24","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1016\/j.transproceed.2010.06.017","volume":"9","author":"AB Karabut","year":"2010","unstructured":"Karabut AB, Gul Karabut E, Kiram TR, Ocak SG, Out O et al (2010) Oxidant and antioxidant activity in rabbit livers treated with zoledronic acid. Transplant Proc 9:3820\u20133822","journal-title":"Transplant Proc"},{"key":"917_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"34","author":"M Uchiyama","year":"1978","unstructured":"Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 34:271","journal-title":"Anal Biochem"},{"key":"917_CR26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/clinchem\/36.8.1440","volume":"36","author":"NK Cortas","year":"1990","unstructured":"Cortas NK, Wakid WN (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440","journal-title":"Clin Chem"},{"key":"917_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3835(96)04140-7","volume":"101","author":"AA Geldof","year":"1996","unstructured":"Geldof AA, Slotman B (1996) Radiosensitizing effect of cisplatin in prostate cancer cell lines. Cancer Lett 101:233\u2013239","journal-title":"Cancer Lett"},{"key":"917_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0360-3016(87)90015-0","volume":"13","author":"L Dewin","year":"1987","unstructured":"Dewin L (1987) Combined treatment of radiation and cisdiamminedichoropltinum (II): a review of experimental and clinical data. Int J Rad Oncol Biol Phys 13:403\u2013426","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"917_CR29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1259\/bjr\/30930369","volume":"82","author":"M Alcaraz","year":"2009","unstructured":"Alcaraz M, Acevedo C, Castillo J, Benavente-Garc\u00eda O, Armero D, Vicente V et al (2009) Liposoluble antioxidants provide an effective radioprotective barrier. Br J Radiol 82:605\u2013609","journal-title":"Br J Radiol"},{"key":"917_CR30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1667\/RR3554.1","volume":"165","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Amano M, Chori J, Park HJ, Williams BW, Ono K, Song CW (2006) Synergistic effects of radiation and beta-lapachone in DU-147 human prostate cancer cells in vitro. Radiat Res 165:525\u2013531","journal-title":"Radiat Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0917-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0917-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0917-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T10:18:34Z","timestamp":1594462714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0917-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0917-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}